Chemo-Free Combo Boosts PFS in First-Line CLL

(MedPage Today) -- A chemotherapy-free investigational combination reduced the risk of disease progression or death versus chemoimmunotherapy with chlorambucil plus obinutuzumab (Gazyva) for patients with chronic lymphocytic leukemia (CLL), a phase...